REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.50
Bid: 63.00
Ask: 66.00
Change: 0.00 (0.00%)
Spread: 3.00 (4.762%)
Open: 64.50
High: 64.50
Low: 64.50
Prev. Close: 64.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: NetScientific invests GBP1 million into Martlet Capital

Thu, 16th Sep 2021 18:04

NetScientific PLC - London-based investor in life sciences companies - Invests GBP1 million into Martlet Capital Ltd, which is looking to raise a total of GBP22 million over the next six months to fund the acquisition of a portfolio of minority interests in the Cambridge high-tech cluster.

Investment leads to initial equity interest of 6.8% in Martlet. Looking ahead, NetScientific expects to establish a follow-on funding vehicle Cambridge Marquity Investments Ltd with Martlet and Saranac Partners. Group will invest GBP100,000 into vehicle for 40% stake.

Current stock price: 115.30 pence

Year-to-date change: up sharply from 46.50p

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2018 10:51

NetScientific Investee Gets Grant From Invest Northern Ireland

LONDON (Alliance News) - NetScientific PLC on Friday said portfolio firm ProAxsis has been awarded a grant in Northern Ireland to develop its protease biomarker technology.The unspecified a

Read more
21 May 2018 11:59

NetScientific Shares Rise As Wanda Reduces Patient Re-Admissions

LONDON (Alliance News) - Shares rose in NetScientific PLC on Monday as it said that majority-owned Wanda Inc reported a 46% reduction in re-admissions to hospitals of high-risk congestive heart in

Read more
29 Mar 2018 13:01

NetScientific Annual Loss Narrows, Seeks Funds To Operate Past June (ALLISS)

LONDON (Alliance News) - NetScientific PLC said on Thursday its loss narrowed in 2017, and it announced plans to raise up to GBP6.0 million.If the funds

Read more
19 Mar 2018 13:08

NetScientific Investee Wanda Health Expands Into Orthpedics

LONDON (Alliance News) - NetScientific PLC said Monday that its portfolio company Wanda Health has expanded into orthopedics via a new partnership with HRS Home listed company

Read more
20 Dec 2016 10:47

NetScientific appoints Google alum Foad Dabiri CEO of Wanda

(ShareCast News) - Healthcare intellectual property company NetScientific said it had appointed Google alum Foad Dabiri chief executive of its San Francisco-based portfolio company Wanda, with immediate effect. He replaced Steve Curd, who was appointed chief executive in September 2015. Since March

Read more
3 Nov 2016 16:47

NetScientific's Vortex Makes European, US Progress On VTX-1 System

Read more
30 Sep 2016 07:51

NetScientific Says ProAxsis Secures European CE Mark For Immunoassay

Read more
27 Sep 2016 15:02

NetScientific's portfolio companies making progress in H1

(ShareCast News) - NetScientific, a healthcare company which commercialises intellectual property, reported a wider loss before tax in the first half the year while many of its core portfolio companies have made progress. Loss before tax widened to £6.1m in the six months ended 30 June from £4.3m th

Read more
27 Sep 2016 09:47

NetScientific Sees "Significant Progress" From Investments In Half

Read more
12 Sep 2016 08:37

NetScientific Says Glycotest Gets Patent For Liver Disease Technology

Read more
19 Aug 2016 06:26

NetScientific's Wanda Launches Healthy Heart App For Women

Read more
3 Aug 2016 16:11

NetScientific's Vortex Biosciences won licence to four patents from Harvard

(ShareCast News) - Biomedical and healthcare technology company NetScientific's portfolio business, Vortex Biosciences, won a license to four patents from Harvard University. The patents cover novel cell electroporation technology (CTC), which Vortex will combine with its CTC enrichment technology t

Read more
22 Jul 2016 08:51

NetScientic Digital Health Platform Deployed By Californian Company

Read more
10 Jun 2016 07:41

Allergy Therapeutics Appoints Skyepharma's Wykeman As Finance Director

Read more
8 Jun 2016 15:06

UK Shareholder Meetings Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.